Infinity to Present at the Goldman Sachs 34th Annual Global Healthcare Conference 34th Annual Goldman Sachs Global Healthcare Conference Business Wire CAMBRIDGE, Mass. -- June 5, 2013 Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) will be presenting at the Goldman Sachs 34^th Annual Global Healthcare Conference on June 12, 2013, at 10:40 a.m. PT in Palos Verdes, CA. A live webcast of Infinity's presentation will be accessible on the “investors/media” section of the company's website, www.infi.com, and will be available for 30 days following the event. About Infinity Pharmaceuticals, Inc. Infinity is an innovative biopharmaceutical company dedicated to discovering, developing and delivering best-in-class medicines to people with difficult-to-treat diseases. Infinity combines proven scientific expertise with a passion for developing novel small molecule drugs that target emerging disease pathways. Infinity’s programs focused on the inhibition of phosphoinositide-3-kinase and heat shock protein 90 are evidence of its innovative approach to drug discovery and development. For more information on Infinity, please refer to the company’s website at www.infi.com. Contact: Infinity Pharmaceuticals, Inc. Kate Murray, 617-453-1179 Kate.Murray@infi.com http://www.infi.com
Infinity to Present at the Goldman Sachs 34th Annual Global Healthcare Conference
Press spacebar to pause and continue. Press esc to stop.